Literature DB >> 11967509

Severe preeclampsia at <25 weeks of gestation: maternal and neonatal outcomes.

Sheri M Jenkins1, Barbara B Head, John C Hauth.   

Abstract

OBJECTIVE: The purpose of this study was to determine maternal and neonatal outcomes of women who were delivered because of severe preeclampsia before 25 weeks of gestation. STUDY
DESIGN: We used a computerized database to identify 3800 women with preeclampsia among 35,937 deliveries from 1991 to 1997. Of these, 39 women (1%) with severe preeclampsia were delivered before 25 weeks of gestation. We abstracted outcomes in these women and their newborns.
RESULTS: All 39 women had severe preeclampsia as defined by clinical and/or laboratory criteria. Thirty-three of the 39 women had severe-range hypertension. Twenty-one women (54%) experienced morbidity that included abruptio placentae (n = 5), HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome (n = 9), renal insufficiency (n = 5), and eclampsia (n = 3). No women required dialysis or intensive care unit admission, and none of the women died. All maternal morbidities reversed after delivery. Twenty-two infants (55%) were live-born. Only 4 infants (10%) survived, all with severe handicaps.
CONCLUSION: In women with severe preeclampsia before 25 weeks of gestation, delivery is associated with minimal short-term maternal morbidities, although neonatal morbidity and death are appreciable.

Entities:  

Mesh:

Year:  2002        PMID: 11967509     DOI: 10.1067/mob.2002.122290

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

1.  Maternal obesity and risk of infant death based on Florida birth records for 2004.

Authors:  Daniel R Thompson; Cheryl L Clark; Betsy Wood; Mary Beth Zeni
Journal:  Public Health Rep       Date:  2008 Jul-Aug       Impact factor: 2.792

Review 2.  Preeclampsia from a renal point of view: Insides into disease models, biomarkers and therapy.

Authors:  Janina Müller-Deile; Mario Schiffer
Journal:  World J Nephrol       Date:  2014-11-06

Review 3.  Pre-eclampsia: pathophysiology, diagnosis, and management.

Authors:  Jennifer Uzan; Marie Carbonnel; Olivier Piconne; Roland Asmar; Jean-Marc Ayoubi
Journal:  Vasc Health Risk Manag       Date:  2011-07-19

4.  Recurrent HELLP Syndrome at 22 Weeks of Gestation.

Authors:  Peter Kascak; Milos Paskala; Peter Antal; Radovan Gajdosik
Journal:  Case Rep Obstet Gynecol       Date:  2017-08-08

5.  Preeclampsia: A risk factor for gestational diabetes mellitus in subsequent pregnancy.

Authors:  Joohyun Lee; Yung-Taek Ouh; Ki Hoon Ahn; Soon Cheol Hong; Min-Jeong Oh; Hai-Joong Kim; Geum Joon Cho
Journal:  PLoS One       Date:  2017-05-22       Impact factor: 3.240

6.  Outcomes following medical termination versus prolonged pregnancy in women with severe preeclampsia before 26 weeks.

Authors:  Mariana A Carvalho; Lina Bejjani; Rossana P V Francisco; Elizabeth G Patino; Alexandre Vivanti; Fernanda S Batista; Marcelo Zugaib; Frédéric J Mercier; Lisandra S Bernardes; Alexandra Benachi
Journal:  PLoS One       Date:  2021-02-03       Impact factor: 3.240

7.  Maternal Preeclampsia Is Associated With Reduced Adolescent Offspring Hip BMD in a UK Population-Based Birth Cohort.

Authors:  Kimberly Hannam; Debbie A Lawlor; Jon H Tobias
Journal:  J Bone Miner Res       Date:  2015-05-14       Impact factor: 6.741

8.  Adverse neonatal outcomes in women with pre-eclampsia in Mulago Hospital, Kampala, Uganda: a cross-sectional study.

Authors:  Paul Kiondo; Nazarius Mbona Tumwesigye; Julius Wandabwa; Gakenia Wamuyu-Maina; Gabriel S Bimenya; Pius Okong
Journal:  Pan Afr Med J       Date:  2014-01-18

9.  The Survival of a 580 g Infant Conceived by In vitro.

Authors:  Marzieh Shiva; Mohammad Reza Shiva; Ladan Mohammadi Yeganeh
Journal:  Int J Fertil Steril       Date:  2011-09-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.